Drug may boost motivation for people with depression

Motivational impairments are a core component of depression and have long been linked with poor treatment outcomes, diminished quality of life, and heightened suicide risk.

Growing evidence suggests one potential cause of low motivation may be persistent inflammation, which suppresses activity within key circuits in the brain.

The new study is the first of its kind to examine the effects of infliximab on both behavioral and brain markers of motivation.